China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory market size has been growing radically in recent years, reaching about RMB6.5 billion with a year-on-year increase of 37.4% in 2015; it is expected to grow rapidly at a rate of 30%-40% over the next three to five years and report RMB29.2 billion in 2020.

There are approximately200 independent clinical laboratory enterprises in China, mainly comprehensive diagnostic chains and special diagnostic enterprises. KingMed Diagnostics, Dian Diagnostics, ADICON Clinical Laboratories, and DaAn Health (invested by Da An Gene), which hold a combined market share of 70% and all adopt chain-based model of comprehensive diagnostic services. By the end of 2015, the four enterprises separately had 31, 26, 20 and 8 independent clinical laboratories. While expanding clinical laboratory services actively, all companies are deploying " laboratory +" industrial chain vigorously.

As a titan in China independent clinical laboratory industry, KingMed Diagnostics earned the revenue of RMB2.5 billion to RMB3 billion in 2015 with 40% market share. In the past two years, KingMed Diagnostics has been involved in production and sale of in vitro diagnostic products through acquisitions and independent R & D; moreover, it has made layout on "laboratory + Internet" services by acquiring GoHeath (Guangzhou Jinzhun), access to Tmall’s online pharmacies, etc..

Second to KingMed Diagnostics, Dian Diagnostics gained the revenue of RMB1.079 billion from independent clinical laboratory in 2015. In recent years, the company has implemented the strategy of horizontal expansion, vertical digging, technological innovation and industrial chain integration aggressively. It has arranged the " diagnosis +" ecosystem which refers to the expansion of other related services such as health management, judicial diagnostics, medicine CRO, cold chain logistics and mobile health with a focus on "diagnostic services + products". Since November 2015, the company has acquired Freda,Yuanding, ShengshiKehua, Faith Medical, Kingpe and many other high-quality IVD distributors for over RMB1 billion totally. In 2015, the company launched a new mode for chain expansion of physical examination services -- a health management center (Hangzhou Full-process International Health Medical Management Center Co., Ltd.) established with Hangzhou Jiebai, Baida Group. Meanwhile, Dian Diagnostics signed strategic cooperation agreements with The Johns Hopkins Hospital and AliHealth respectively to explore the "diagnosis + Internet" business mode energetically. At the beginning of 2016, Dian Diagnostics collaborated with Tigermed to set up a joint venture -- Shanghai Teddy Medical Institute Co., Ltd., marking the former’s foray into pharmaceutical CRO.

The third-ranked ADICON Clinical Laboratories which still enjoys superiority in East China has not realized the distribution of nationwide chain operation, but its special laboratory items have showed strong competitiveness. The company is not only authorized by the global pharmaceutical giant Roche to become "Roche’s Demonstration Laboratory in China", but also cooperates with Siemens Healthineers, Japan SRL, South Korea SCL, France Bio Mérieux, etc. in medical diagnostics.

Being bullish about the prospects of the Chinese independent clinical laboratory market, a number of small and medium Chinese independent clinical laboratory companies have drawn or plan to draw support fromthe capital market to further expand the clinical laboratory market. In 2014-mid-2016, Surexam Biotechnology, Shanghai Labway, Beijing Lepu, Shanghai Biotecan, Jiangsu Superbio, Beijing Lawke and other companies went public at NEW OTCBB in China. Wherein, Jiangsu Superbio witnessed the fastest revenue growth in clinical laboratory, namely the year-on-year surge of 161.0% in 2015; Shanghai Biotecan took the second place with the CAGR of 92.1% in 2013-2015. Shanghai Labway Clinical Laboraory obtained the clinical laboratory revenue of RMB127.8 million in 2015, but the revenue growth has slowed down due to the construction and expansion of laboratories in recent years.

Independent Clinical Laboratory Industry ChainComparison of Independent Clinical Laboratory Undertakers between China and USAPolicies Concerning Independent Clinical Laboratory Industry in China, 2010-2016Market Share of Independent Clinical Laboratories in Major CountriesU.S. Independent Clinical Laboratory Market Share by Test ItemU.S. Clinical Laboratory Market Share by Demand SideRevenue and Net Income of Quest, 2009-2016Revenue of Quest Diagnostics by Business, 2014-2015Major M&As of Quest Diagnostics, 2006-2015Revenue and Operating Income of LabCorp, 2010-2016Revenue Breakdown of LabCorp by Business, 2013-2016Major M&As of LabCorp, 2007-2015Market Scale of independent clinical laboratory industry in China,2013-2016Revenue CAGR of Some Independent Clinical Laboratory Enterprises in China, 2012-2015Market Share of Major Enterprises in China’s Independent Clinical Laboratory Industry, 2015Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, 2015Development History of In Vitro Diagnostic Industry in ChinaMarket Size of In Vitro Diagnostic Industry in China, 2009-2015Market Structure of In Vitro Diagnostic Reagent Industry in China, 2015Comparison of Diagnostic Instrument Varieties between Domestic and Foreign EnterprisesCompetition Pattern of Diagnostic Reagent Industry in ChinaIVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2013-2015Business Revenue and Inspection Revenue of Public Hospitals in China, 2014Per Capita Inspection Fees and % of Outpatient Expenses of Outpatients in Chinese Hospitals, 2010-2014Per Capita Inspection Fees and % of Hospitalization Expenses of Inpatients in Chinese Hospitals, 2010-2014Business Revenue and Inspection Revenue of Public Hospitals in China by Type of Visit, 2014Medical Services of Health Agencies in China, 2012-2015Number of Medical Institutions in China, 2012-2015Health Expenditure and % of GDP in China, 1980-2015Per Capita Health Expenditure and YoY Growth in China, 2006-2015Revenue and Net Income of KingMed Diagnostics, 2012-2015Revenue Breakdown of KingMed Diagnostics by Business, 2012-2015Revenue Breakdown of KingMed Diagnostics by Region, 2012-2015Gross Margin of KingMed Diagnostics by Business, 2012-2015R&D Costs and % of Total Revenue of KingMed Diagnostics, 2012-2015Proposed Fundraising & Investment Projects and Value of KingMed Diagnostics, 2016 Distribution of Independent Clinical Laboratories of KingMed Diagnostics, as of June 2016 Capacity and Output of KingMed Diagnostics (by Business), 2014-2015Service Prices of KingMed Diagnostics (by Business), 2012-2015Revenue of Dian Diagnostics from Top 5 Clients and % in Total Revenue, 2012-2015Revenue of KingMed Diagnostics from Top 5 Clients and % of Total Revenue, 2014-2015Procurement of KingMed Diagnostics from Top 5 Suppliers and % of Total Procurement, 2014-2015Revenue and Net Income of KingMed Diagnostics, 2015-2020Revenue and Net Income of Dian Diagnostics, 2010-2016Revenue Breakdown of Dian Diagnostics by Product, 2010-2016Revenue Breakdown of Dian Diagnostics by Region, 2009-2016Gross Margin of Dian Diagnostics, 2010-2016Gross Margin of Dian Diagnostics by Product, 2010-2015R&D Costs and % of Total Revenue of Dian Diagnostics, 2010-2016Dian Diagnostics’ Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2016Revenue of Dian Diagnostics’ Top 5 Clients and % in Total Revenue, 2011-2016Revenue of Dian Diagnostics from Top 5 Clients and % of Total Revenue, 2015-2016Procurement of Dian Diagnostics’ Top 5 Suppliers and % in Total Procurement, 2011-2016Procurement of Dian Diagnostics’ Top 5 Suppliers and % in Total Procurement, 2015-2016 Revenue and Net Income of Dian Diagnostics, 2015-2020ERevenue and Net Income of Da An Gene, 2010-2016Revenue Breakdown of Da An Gene by Business, 2010-2016Revenue Breakdown of Da An Gene by Region, 2010-2016Gross Margin of Da An Gene, 2010-2016Gross Margin of Da An Gene by Business, 2010-2016R&D Costs and % of Total Revenue of Da An Gene, 2011-2016Main Assets and Business of Da An GeneIndustrial Chain Layout of Da An GeneMedical Resources of Sun Yat-Sen UniversityDa An Gene’s Revenue from Independent Clinical Laboratory and YoY Growth, 2010-2016Revenue of Da An Gene from Top 5 Clients and % in Total Revenue, 2014-2015Top 5 Suppliers of Da An Gene, 2014-2015Revenue and Net Income of Da An Gene, 2015-2020ERevenue and Net Income of Shanghai Labway, 2013-2016Revenue Breakdown of Shanghai Labway by Product, 2013-2016Gross Margin of Shanghai Labway by Product, 2013-2016R&D Costs and % of Medical Diagnosis Service’s revenue of Nymphavn Biotechnology, 2013-2016Revenue from and Gross Margin of Independent Clinical Laboratory Business of Medicalsystem Biotechnology, 2013-2016Revenue of Shanghai Labway’s Top 5 Clients and % in Total Revenue, 2013-2015Revenue of Shanghai Labway’s Top 5 Clients and % in Total Revenue, 2015Procurement of Shanghai Labway’ Top 5 Suppliers and % in Total Procurement, 2013-2015Procurement of Shanghai Labway’ Top 5 Suppliers and % in Total Procurement, 2015 Revenue and Net Income of Nymphavn Biotechnology, 2009-2016Revenue Breakdown of Nymphavn Biotechnology by Product, 2009-2016Gross Margin of Nymphavn Biotechnology, 2009-2016Gross Margin of Nymphavn Biotechnology by Product, 2009-2016R&D Costs and % of Total Revenue of Nymphavn Biotechnology, 2011-2016Revenue from and Gross Margin of Independent Clinical Laboratory Business of Nymphavn Biotechnology, 2009-2016Revenue and Net Income of Nymphavn Biotechnology, 2015-2020ESubsidiaries and Main Businesses of Surexam BiotechnologyRevenue and Net Income of Surexam Biotechnology, 2011-2016Revenue Breakdown of Surexam Biotechnology by Business, 2011-2016Gross Margin of Surexam Biotechnology, 2011-2016Gross Margin of Surexam Biotechnology by Product, 2009-2016R&D Costs and % of Total Revenue of Surexam Biotechnology, 2011-2016Revenue from and Gross Margin of Independent Clinical Laboratory Business of Surexam Biotechnology, 2011-2016Revenue of Surexam Biotechnology from Top 5 Clients and % of Total Revenue, 2015Procurement of Surexam Biotechnology from Top 5 Suppliers and % of Total Procurement, 2015Revenue and Net Income of Surexam Biotechnology, 2015-2020ERevenue and Net Income of Medicalsystem Biotechnology, 2011-2016Revenue Breakdown of Medicalsystem Biotechnology by Product, 2011-2016Gross Margin of Medicalsystem Biotechnology by Product, 2011-2016R&D Costs and % of Total Revenue of Medicalsystem Biotechnology, 2011-2016Projects Proposed/Under Construction of Medicalsystem BiotechnologyRevenue from and Gross Margin of Independent Clinical Laboratory Business of Medicalsystem Biotechnology, 2011-2016Revenue of Medicalsystem Biotechnology’ Top 5 Clients and % in Total Revenue, 2011-2016Procurement of Medicalsystem Biotechnology’ Top 5 Suppliers and % in Total Procurement, 2011-2016Revenue and Net Income of Medicalsystem Biotechnology, 2015-2020ERevenue and Net Income of Beijing Lawke, 2013-2016Revenue Breakdown of Beijing Lawke by Region, 2014-2016Gross Margin of Beijing Lawke by Business, 2013-2016Revenue and Net Income of Beijing Lawke, 2015-2020ERevenue and Net Income of Lepu Gene, 2013-2016Gross Margin of Lepu Gene,2013-2016Revenue and Net Income of Lepu Gene, 2015-2020ERevenue and Net Income of Biotecan,2013-2016Revenue Breakdown of Shanghai Biotecan by Business 2014-2016Gross Margin of Shanghai Biotecan, 2014-2016Clinical Laboratory Revenue of Shanghai Biotecan and % of Total Revenue, 2013-2016 Revenue and Net Income of Biotecan, 2015-2020ERevenue and Net Income of Jiangsu Superbio, 2014-2015Revenue Breakdown of JiangsuSuperbio by Business,2014-2015Revenue Breakdown of S Jiangsu Superbio by Region,2014-2015Gross Margin of Jiangsu Superb by business,2014-2015Revenue of Jiangsu Superb from Top 5 Clients and % of Total Revenue, 2014-2015Procurement of Jiangsu Superb from Top 5 Suppliers and % of Total Procurement, 2014-2015Revenue and Net Income of Jiangsu Superbio, 2015-2020Milestones of Kindstar GlobalSome Strategic Partners of ADINOVOChinese Independent Clinical Laboratory Market Size and YoY Growth, 2014-2020ERevenue of Major Independent Clinical Laboratory Enterprises in China, 2011-2016Clinical Laboratory Revenue of Major Enterprises in Independent Clinical Laboratory Industry in China, 2012-2016Gross Margin of Major Enterprises in Independent Clinical Laboratory Industry in China, 2012-2016Gross Margin of Clinical Laboratory Business of Major Independent Clinical Laboratory Enterprises in China, 2012-2016

Published By:
Research In ChinaProduct Code:
Research In China2293

Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and well share relevant market report titles for you to explore.

DNA forensics is a branch of forensic science that focuses on the use of genetic material in criminal investigation to answer questions pertaining to legal situations, including criminal and civil cases.
Scope of the Report:
This report focuses ...

Notes:
Sales, means the sales volume of Laboratory Swab
Revenue, means the sales value of Laboratory Swab
This report studies sales (consumption) of Laboratory Swab in United States market, focuses on the top players, with sales, price, revenue ...

The global cartilage repair/ cartilage regeneration market is projected to reach USD 779.8 million by 2021 from USD 414.6 million in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.
In this report, the cartilage repair/ c...

Notes:
Sales, means the sales volume of Microarray
Revenue, means the sales value of Microarray
This report studies sales (consumption) of Microarray in United States market, focuses on the top players, with sales, price, revenue and market shar...

Notes:
Production, means the output of Biosimulation
Revenue, means the sales value of Biosimulation
This report studies the global Biosimulation market, analyzes and researches the Biosimulation development status and forecast in United States,...

Notes:
Sales, means the sales volume of G-Protein Coupled Receptor
Revenue, means the sales value of G-Protein Coupled Receptor
This report studies sales (consumption) of G-Protein Coupled Receptor in United States market, focuses on the top pla...

Research Support / Custom Research

If this business study does not have the data and information analysis you need,
contact us with your research requirements. We explore available market research
reports to map your needs and share report titles with you. Alternatively, we can
also offer custom research that suits your budget and timelines. Share your information
requirements here.

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.